/
Login
Analysis Scores
Damodaran ?
23/100
Dalio Risk ?
96/100
Piotroski ?
5/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
$13.4
Pahalı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
-56.2%
ROIC ?
8.9%
DCF Value ?
24.64
Debt Cycle?
Early Expansion
Data
Data ?
746
2023-09-14 → 2026-09-03
Risk Analysis (VaR)
Çok Yüksek
252 days
Annual Volatility ?
%77.9
VaR 95% ?
%7.72
daily max loss
VaR 99% ?
%11.07
daily max loss
CVaR 95% ?
%9.17
expected loss (tail)
Max Drawdown ?
%49.0
18.06.2026 → 29.07.2026
Skewness ?
0.80
Parametrik%7.72
Historik%7.74
Cornish-Fisher%6.34
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (234.86), TRAMA-99 line's %11.1 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 234.86
TRAMA: 264.3034
Difference: %-11.1
Profitability
Net Profit Margin
%20.9
Net profit margin %20.9 — very strong. Compared to previous quarter -0.1 point decrease.
ROE – Özkaynak Getirisi (TTM)
%12.3
ROE %12.3 — moderate return on equity.
EBITDA Margin
%13.4
EBITDA margin %13.4 — moderate operational efficiency.
Gross Profit Margin
%97.2
Gross profit per revenue %97.2. Strong pricing power.
Free Cash Flow Margin (TTM)
%28.5
TTM Free Cash Flow is %28.5'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
100.0x
Sector: 51.6x
F/K 100.0x — sector median's (51.6x) %94 above. Expensive zone.
P/B Ratio
28.67x
Sector: 4.59x
PD/DD 28.67x — sector median's %525 above. Expensive book value.
Indebtedness
Current Ratio
5.25x
Current ratio 5.25x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
0.4x
Net Borç/EBITDA 0.4x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.05x
Low leverage — majority of assets financed by equity.
Growth
Revenue Growth (YoY)
%+22.4
Revenue YoY %22.4 grew — healthy growth rate.
Net Profit Growth (YoY)
%+107.7
Net profit YoY %107.7 increased (2026/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
32/100
Weak robustness (32/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-56.2%
Minus %56.2 expected value (101.73) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 58.13 | P/B target: 58.13 | EV/EBITDA target: 58.13 | DCF target: 58.13
Damodaran Valuation
23/100
Low Damodaran score (23/100). ROIC (%8.9) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
96/100
Low debt risk (96/100). Borç/EBITDA 0.4x — in healthy range.
Leverage: 95/100 | Debt Service: 100/100 | Quality: 88/100
ROIC – Sermaye Getirisi
%8.9
ROIC (%8.9) cost of capitaln (10.9%) below → destroying value.
WACC: %10.9
DCF Discounted Cash Flow
24.64
DCF (24.64) current price %89.4 below — cash flows do not support current price.
Current price: 232.53
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
5/9
Moderate Piotroski (5/9). Some balance sheet criteria met, some missing. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
$13.4
Güncel fiyat Graham valuenin %94.2 üzerinde ($13.4) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
100.0x
vs 51.6x
Sector mediannın %94 above — expensive
P/B Ratio
28.67x
vs 4.59x
Compared to sector %525 more expensive (by book value)
EV/EBITDA
211.8x
vs 20.6x
Compared to sector %928 higher EV/EBITDA
ROIC vs WACC
%8.9
vs %10.9 WACC
ROIC 2.0 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%20.2
vs %22.4 EBITDA margin
TTM net profit margin %20.2
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
ARM — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.